"Novel Treatments for Familial Parkinson's Disease Unveiled at Science Competition"
In the first open science competition run by Canadian nonprofit Conscience, seven molecules were identified as potential treatments for familial Parkinson's disease, marking a win for open science and collaboration in drug discovery. The competition, funded by The Michael J. Fox Foundation for Parkinson’s Research, aimed to make AI a tool for drug discovery and resulted in the identification of new chemical starting points for potential treatments. The entire dataset of the competition has been made available to the public, promoting transparency and collaboration in therapeutic development. This approach may improve the efficiency and cost-effectiveness of drug discovery and development, with additional challenges underway for other conditions.